Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Effective?
Diabetic macular oedema (DMO) is a common ocular problem among patients with diabetic retinopathy, which is sight-threatening and leads to blindness. The gold standard treatment for DMO had been focal/grid laser photocoagulation that achieved stabilisation of disease progression. However, newer phar...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2017-10-01
|
| Series: | European Medical Journal Diabetes |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/diabetes/article/anti-vascular-endothelial-growth-factor-therapy-in-diabetic-macular-oedema-is-it-effective/ |